Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case-control study.
van Velzen AS, Eckhardt CL, Peters M, Oldenburg J, Cnossen M, Liesner R, Morfini M, Castaman G, McRae S, van der Bom JG, Fijnvandraat K; INSIGHT consortium.
van Velzen AS, et al. Among authors: peters m.
Br J Haematol. 2020 Jun;189(6):1182-1191. doi: 10.1111/bjh.16490. Epub 2020 Mar 22.
Br J Haematol. 2020.
PMID: 32201943
Free PMC article.